PsychotherapyNCT07147205
Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine
A study testing Therapy in people with Psychotherapy and Integrative Medicine, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
To learn more about your experience participating in a virtual Meaning-Centered Psychotherapy group. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Psychotherapy, Integrative Medicine
- What is being tested?
- Therapy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 72 participants
- Where
- 1 siteUnited States
- Study dates
- 3 Oct 2025to 1 Feb 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
None listed.
Who cannot join
- Children will not be enrolled in this study.
- Pregnant women will not be enrolled in this study.
- Cognitively impaired subjects will not be enrolled in this study.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
MD Anderson Cancer Center
Houston, Texas, 77030
Elizabeth C Conti, MD, 713-563-7630, ecconti@mdanderson.org
Elizabeth C Conti, MD
About this study
To learn more about your experience participating in a virtual Meaning-Centered Psychotherapy group.
Read the detailed description
Primary Objectives
The objectives are to describe the characteristics and outcomes of participants who attend at least one session of MCGP:
- Describe demographic, clinical characteristics, reasons for referral, and IMC utilization data for participants who attend MCGP.
- Examine anxiety, depression, quality of life, meaning in life, and fear of cancer recurrence before and after participation in MCGP.
- Describe satisfaction and qualitative feedback from group participants, including perceived effectiveness and outcomes, experiences participating in the group virtually, and reactions to specific elements of the therapy modified for cancer survivors, length of group (90 minutes), and the nature of a closed group within the IMC. Secondary Objectives
- Examine whether demographic, clinical, or symptoms-based (pre) measures are associated with number of MCGP sessions attended.
- Examine whether number of sessions attended is associated with change in outcome measures.
- Conditions
- Psychotherapy, Integrative Medicine
- Being tested
- Therapy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TherapyOther
MCGP will be delivered in 8 weekly sessions for 90 minutes over Zoom by a licensed doctoral level psychologist.
| Study group | Role | What they receive |
|---|---|---|
| Intervention with Meaning-Centered Group Psychotherapy | Experimental | Not described Receives: Other: Therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-report Questionnaires
Measured: Through study completion; an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Aug 2025
- Study start3 Oct 2025
- Primary completion1 Feb 2027 (estimated)
- Study completion1 Feb 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PsychotherapyStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 72 participants (estimated)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Elizabeth C Conti, MD, Principal investigator, M.D. Anderson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07147205
- Sponsor's protocol ID
- 2025-0994
- Other IDs
- NCI-2025-06343
- Status last verified
- Sep 2026
- First submitted
- 27 Aug 2025
- Last updated
- 16 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine
- ClinicalTrials.gov ID
- NCT07147205
- Acronym / sponsor ID
- 2025-0994
- Conditions
- Psychotherapy, Integrative Medicine
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 72 participants (estimated)
- Lead sponsor
- M.D. Anderson Cancer CenterUniversity, hospital or other
- Study start
- 3 Oct 2025 (actual)
- Primary completion
- 1 Feb 2027 (estimated)
- Study completion
- 1 Feb 2029 (estimated)
- First posted
- 29 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To learn more about your experience participating in a virtual Meaning-Centered Psychotherapy group.
Detailed description
Primary Objectives
The objectives are to describe the characteristics and outcomes of participants who attend at least one session of MCGP:
- Describe demographic, clinical characteristics, reasons for referral, and IMC utilization data for participants who attend MCGP.
- Examine anxiety, depression, quality of life, meaning in life, and fear of cancer recurrence before and after participation in MCGP.
- Describe satisfaction and qualitative feedback from group participants, including perceived effectiveness and outcomes, experiences participating in the group virtually, and reactions to specific elements of the therapy modified for cancer survivors, length of group (90 minutes), and the nature of a closed group within the IMC. Secondary Objectives
- Examine whether demographic, clinical, or symptoms-based (pre) measures are associated with number of MCGP sessions attended.
- Examine whether number of sessions attended is associated with change in outcome measures.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Intervention with Meaning-Centered Group Psychotherapy | Experimental | Other: Therapy |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (0 listed)
Key exclusion criteria (3 listed)
- Children will not be enrolled in this study.
- Pregnant women will not be enrolled in this study.
- Cognitively impaired subjects will not be enrolled in this study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TherapyMCGP will be delivered in 8 weekly sessions for 90 minutes over Zoom by a licensed doctoral level psychologist. | Other | Intervention with Meaning-Centered Group Psychotherapy |
Primary outcome
Self-report Questionnaires
Time frame: Through study completion; an average of 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2026.
- MD Anderson Cancer CenterLink provided by the sponsor.
Related trials for Psychotherapy
Not yet recruiting
A Transdiagnostic Sleep Health Intervention for Veterans With PTSD
Stress Disorders, Post-Traumatic, Sleep Initiation and Maintenance Disorders
RecruitingObservational study
Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy
Irritability, Disruptive Mood Dysregulation Disorder
Not yet recruitingPhase 2
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Recruiting
Application of Meaning-Based Psychotherapy to a Sample of Patients With Chronic Pain
Chronic Pain
Recruiting
Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings
Suicide, Attempted, Suicide Ideation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Elizabeth C Conti, MD principal investigator
M.D. Anderson Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Therapy in people with Psychotherapy and Integrative Medicine, run by M.D. Anderson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Elizabeth C Conti, MD (7135637630, ecconti@mdanderson.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-report Questionnaires (time frame: Through study completion; an average of 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.